【2h】

A vector-free microfluidic platform for intracellular delivery

机译:用于细胞内递送的无载体微流平台

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intracellular delivery of macromolecules is a challenge in research and therapeutic applications. Existing vector-based and physical methods have limitations, including their reliance on exogenous materials or electrical fields, which can lead to toxicity or off-target effects. We describe a microfluidic approach to delivery in which cells are mechanically deformed as they pass through a constriction 30–80% smaller than the cell diameter. The resulting controlled application of compression and shear forces results in the formation of transient holes that enable the diffusion of material from the surrounding buffer into the cytosol. The method has demonstrated the ability to deliver a range of material, such as carbon nanotubes, proteins, and siRNA, to 11 cell types, including embryonic stem cells and immune cells. When used for the delivery of transcription factors, the microfluidic devices produced a 10-fold improvement in colony formation relative to electroporation and cell-penetrating peptides. Indeed, its ability to deliver structurally diverse materials and its applicability to difficult-to-transfect primary cells indicate that this method could potentially enable many research and clinical applications.
机译:大分子的细胞内递送是研究和治疗应用中的挑战。现有的基于载体的物理方法具有局限性,包括对外源材料或电场的依赖,这可能导致毒性或脱靶效应。我们描述了一种微流控递送方法,其中细胞通过收缩时比细胞直径小30-80%,从而使细胞发生机械变形。压缩和剪切力的受控施加导致形成瞬态孔,该瞬态孔使材料能够从周围的缓冲液扩散到细胞质中。该方法已证明能够将多种材料(例如碳纳米管,蛋白质和siRNA)递送至11种细胞类型,包括胚胎干细胞和免疫细胞。当用于传递转录因子时,相对于电穿孔和细胞穿透肽,微流体装置在菌落形成方面产生了10倍的改善。实际上,其传递结构多样的材料的能力及其对难以转染的原代细胞的适用性表明,该方法可能潜在地实现许多研究和临床应用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号